Stock info Agile Therapeutics | Filter  Basic-Info

Stock: Agile Therapeutics (US broad)

Last Price 0.56 Max Price 11.75
Min Price 0.54 1 Year return -97.13
Sector Health Care Subsector Pharmaceuticals
Annual report 2017

Loading...

Contact info:Street: 101 Poor Farm RoadZip Code: NJ 08540City: PrincetonCountry: USAPhone: 609-683-1880Email: info@agiletherapeutics.comWebsite: www.agileeraeuics.comCEO: Mr. Alfred F. AltomariCFO: Mr. Scott M. Coiante

Sector Review Agile Therapeutics

Loading...
Year Turnover Total sector Market share
2019 0 615,634 0.00 %
2020 1 638,070 0.00 %
2021 4 727,968 0.00 %
2022 11 787,273 0.00 %
2023 0 0 0.00 %

Advice Agile Therapeutics

No Records Found




News Agile Therapeutics

No Records Found

Annual reports Agile Therapeutics

2017 2018 2019 2020 2021

Profile Agile Therapeutics

Agile Therapeutics


The past year yielded positive returns for Agile Therapeutics investors

Over the past year the company' stock lost around 12 percent. Over the period from December 2011 till December 2016 the stock lost on average 0 percent.

Agile Therapeutics's headquarter is based in Princeton. Agile Therapeutics is mostly active in the health care eq. & services sector. Mr. Alfred F. Altomari is leading the company as CEO. The CFO of the company is Mr. Scott M. Coiante. Between 2006 and 2016 the global health care companies gained around 102 percent. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-2016) there is a plus of 102 percent.

Agile Therapeutics didn't pay out any dividends (in the past 5 years).

Healthy financed: not so much debt Agile Therapeutics

At the end of 2015 the American company had a balance sheet of around 50,71 million dollars. At the end of 2015 the total debt positon equaled 20,97 million dollars. This is around 41,35 percent of the total balance sheet. At the end of 2016 the American company was traded with a price/earnings-ratio of around -5. So investors paid -5 times the company's 2015's EPS. Based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the American company's market capitalization equaled around 208,06 million dollars. At the end of 2015 the American company had around 22,02 million stocks listed.

All the annual reports of Agile Therapeutics are available here. More information about Agile Therapeutics can be found it's website. .


Results Agile Therapeutics

Results
2015
2016
2017
2018
2019
2020
Revenue
0
0
0
0
0
1
Costs
30
29
28
20
19
53
Profit
-30
-29
-28
-20
-19
-52
Margin of profit
0.0
0.0
0.0
0.0
0.0
-6913.33
ROI
-102.02
-67.96
-77.92
-98.07
-40.68
-105.11

Balance Agile Therapeutics

Balance
2015
2016
2017
2018
2019
2020
Equity
30
42
36
20
46
49
Debt
21
22
14
2
4
24
Total assets
50
64
51
22
50
73
Solvency
58.98
66.21
71.78
90.08
92.35
67.52
Cash
34
49
36
8
34
54
Cashflow
-25
-23
-25
-17
-16
-47
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
-1.23
-1.08
-1.72
-7.61
-4.14
-1.99

Details Agile Therapeutics

Details
2016
2017
2018
2019
2020
Price
390.40
228.00
107.60
23.04
100.00
Eps
-2033.08
-1829.56
-1152.76
-752.78
-1224.64
Price/earnings-ratio
-0.19
-0.12
-0.09
-0.03
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
2940.89
2125.22
1173.36
1310.51
1126.77
Market to book
7.53
9.32
10.90
56.88
2012.09
Cashflow per stock
-1620.31
-1437.10
-983.13
-449.44
-1080.63
Stocks
0
0
0
0
Market Cap
5.61
3.90
1.85
0.80
0.02

Dividend Agile Therapeutics


Price info Agile Therapeutics

Date
Price
22 Mar 2024
0.56
18 Mar 2024
0.54
15 Mar 2024
0.59
12 Mar 2024
0.72
11 Mar 2024
0.75
09 Mar 2024
0.75
07 Mar 2024
0.81
01 Mar 2024
0.80
29 Feb 2024
0.77
27 Feb 2024
0.81
22 Feb 2024
0.99
21 Feb 2024
1.05
20 Feb 2024
1.20
15 Feb 2024
1.20
14 Feb 2024
1.20
13 Feb 2024
1.19
09 Feb 2024
1.20
08 Feb 2024
1.28
07 Feb 2024
1.51
06 Feb 2024
1.43
05 Feb 2024
1.47
01 Feb 2024
1.53
31 Jan 2024
1.61
30 Jan 2024
1.60
27 Jan 2024
1.58
25 Jan 2024
1.59
24 Jan 2024
1.45
23 Jan 2024
1.48
16 Jan 2024
1.87
11 Jan 2024
1.66